2011
DOI: 10.2174/156652411794859232
|View full text |Cite
|
Sign up to set email alerts
|

microRNAs in Stroke Pathogenesis

Abstract: Stroke is one of the leading causes of death and disability worldwide. There are two major types of stroke: cerebral ischemia caused by obstruction of blood vessels in the brain and haemorrhagic stroke that is triggered by the disruption of blood vessels. Thrombolytic therapy involving recombinant tissue plasminogen activator (rtPA) has been shown to be beneficial only when used within 4.5 hours of onset of acute ischemic stroke. rtPA treatment beyond this time window has been found to be unsuitable and usuall… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
43
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 91 publications
(44 citation statements)
references
References 0 publications
1
43
0
Order By: Relevance
“…MiRNAs can fit this need as they are known to be released into both blood and CSF and remain stable for days. Hence, many studies evaluated their usefulness as biomarkers for identifying the onset of stroke, TBI and SCI (Reid et al, 2011; Tan et al, 2011; Wang et al, 2013). …”
Section: Micrornas As Potential Biomarkers For Acute Cns Injuriesmentioning
confidence: 99%
“…MiRNAs can fit this need as they are known to be released into both blood and CSF and remain stable for days. Hence, many studies evaluated their usefulness as biomarkers for identifying the onset of stroke, TBI and SCI (Reid et al, 2011; Tan et al, 2011; Wang et al, 2013). …”
Section: Micrornas As Potential Biomarkers For Acute Cns Injuriesmentioning
confidence: 99%
“…NcRNAs have become a focus in biomedical research in the last half decade and are now regarded as important and essential mediators in major biological/physiological processes impacting development, differentiation, and metabolism, as well as pathologies in a variety of human diseases (Qureshi and Mehler, 2012; Schonrock et al, 2012; Suarez and Sessa, 2009; Taft et al, 2010; Vemuganti, 2013; Wienholds and Plasterk, 2005; Yin et al, 2014). So far in the stroke field, the role of a specific class of small ncRNAs, miRNAs, was mainly investigated in the pathogenesis of stroke (Eacker et al, 2013; Liu et al, 2013; Ouyang et al, 2013; Rink and Khanna, 2010; Saugstad, 2010; Tan et al, 2011; Vemuganti, 2010; Yin et al, 2013b, 2014). Notably, our research team has focused on studying the functional significance of stroke-associated endothelial ncRNAs with a special focus on miRNAs in cerebral endothelial pathophysiology after stroke (Yin et al, 2010a; Yin et al, 2013a; Yin et al, 2013b, 2014; Yin et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…So far in the stroke field, the role of a specific class of small ncRNAs, miRNAs, was mainly investigated (Rink and Khanna, 2010; Saugstad, 2010; Vemuganti, 2010; Tan et al, 2011; Eacker et al, 2013; Liu et al., 2013; Ouyang et al, 2013; Yin et al, 2013a). Moreover, recent breakthrough microarray profiling studies identifying stroke-responsible alteration of piRNAs (Dharap et al, 2011) and lncRNAs (Dharap et al, 2012; Dharap et al, 2013; Vemuganti, 2013) underscore the importance of other ncRNAs in the pathogenesis of ischemic stroke.…”
Section: Introductionmentioning
confidence: 99%